HeartBeat bio announces publication in Cell demonstrating the power of human heart organoids dgap.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dgap.de Daily Mail and Mail on Sunday newspapers.
red-stars.com data AG made the investment.
The company intends to use the funds to establish operations, build up an experienced team over the next 12 months, and develop the Cardioid technology into a platform solution for compound screening.
Led by Michael Krebs, CEO, HeartBeat.bio is developing a high-throughput 3D screening platform for heart diseases using self-organizing human cardiac organoids (Cardioids). The Cardioid technology has been invented by the Mendjan lab at IMBA, a leading hub in organoid research.
This human organoid screening platform enables the automated, reproducible, and cost-effective large-scale generation and analysis of cardiac organoids, making it suitable for high-throughput compound screenings.